Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6369)
All Articles published online
|
Jun 28, 2011 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zavoral M, Minarikova P, Zavada F, Salek C, Minarik M. Molecular biology of pancreatic cancer. World J Gastroenterol 2011; 17(24): 2897-2908 [PMID: 21734801 DOI: 10.3748/wjg.v17.i24.2897] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i24/2897.htm |
| Number | Citing Articles |
| 1 |
Thiruvengadam Arumugam, Vijaya Ramachandran, Duoli Sun, Zhenghong Peng, Ashutosh Pal, David S. Maxwell, William G. Bornmann, Craig D. Logsdon. Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy. Molecular Cancer Therapeutics 2013; 12(5): 654 doi: 10.1158/1535-7163.MCT-12-0771
|
| 2 |
Ning Li, Xuefeng Wu, Ryan G. Holzer, Jun-Hee Lee, Jelena Todoric, Eek-Joong Park, Hisanobu Ogata, Anna S. Gukovskaya, Ilya Gukovsky, Donald P. Pizzo, Scott VandenBerg, David Tarin, Çiǧdem Atay, Melek C. Arkan, Thomas J. Deerinck, Jorge Moscat, Maria Diaz-Meco, David Dawson, Mert Erkan, Jörg Kleeff, Michael Karin. Loss of acinar cell IKKα triggers spontaneous pancreatitis in mice. Journal of Clinical Investigation 2013; 123(5): 2231 doi: 10.1172/JCI64498
|
| 3 |
Lin Li, Po Sing Leung. Use of herbal medicines and natural products: An alternative approach to overcoming the apoptotic resistance of pancreatic cancer. The International Journal of Biochemistry & Cell Biology 2014; 53: 224 doi: 10.1016/j.biocel.2014.05.021
|
| 4 |
Yun-Peng Peng, Yi Zhu, Jing-Jing Zhang, Ze-Kuan Xu, Zhu-Yin Qian, Cun-Cai Dai, Kui-Rong Jiang, Jun-Li Wu, Wen-Tao Gao, Qiang Li, Qing Du, Yi Miao. Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer. Journal of Translational Medicine 2013; 11(1) doi: 10.1186/1479-5876-11-262
|
| 5 |
Aibek E. Mirrakhimov, Farah N. Khan. Epidural Brain Metastases in a Patient with Early Onset Pancreatic Cancer: A Case Report and Literature Review. Case Reports in Oncological Medicine 2012; 2012: 1 doi: 10.1155/2012/962305
|
| 6 |
Andrej Udelnow, Doris Henne-Bruns, Uwe Knippschild, Walter Halangk, Christiane Bruns, Zuhir Halloul, Peter Würl, Lukasz Filip Grochola. MDM2 SNP 309G Allele Is Associated With Younger Age at Surgery in Chronic Pancreatitis Patients. Pancreas 2016; 45(4): e11 doi: 10.1097/MPA.0000000000000602
|
| 7 |
Jing Cui, Hao Li, Ying Wang, Tian Tian, Chao Liu, Yanan Wang, Shukai Sun, Baisui Feng. WITHDRAWN: Skullcapflavone I has a potent anti-pancreatic cancer activity by targeting miR-23a. Life Sciences 2019; doi: 10.1016/j.lfs.2019.05.025
|
| 8 |
Lauren A. Mauro, Joseph M. Herman, Elizabeth M. Jaffee, Daniel A. Laheru. Abeloff's Clinical Oncology. 2014; : 1397 doi: 10.1016/B978-1-4557-2865-7.00081-3
|
| 9 |
|
| 10 |
Jing Cui, Hao Li, Ying Wang, Tian Tian, Chao Liu, Yanan Wang, Shukai Sun, Baisui Feng. Skullcapflavone I has a potent anti‐pancreatic cancer activity by targeting miR‐23a. BioFactors 2020; 46(5): 821 doi: 10.1002/biof.1621
|
| 11 |
Carlo Caputo, Michela Falco, Anna Grimaldi, Angela Lombardi, Chiara Carmen Miceli, Mariateresa Cocule, Marco Montella, Luca Pompella, Giuseppe Tirino, Severo Campione, Chiara Tammaro, Antonio Cossu, Grazia Fenu Pintori, Margherita Maioli, Donatella Coradduzza, Giovanni Savarese, Antonio Fico, Alessandro Ottaiano, Giovanni Conzo, Madhura S. Tathode, Fortunato Ciardiello, Michele Caraglia, Ferdinando De Vita, Gabriella Misso. Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma. Cancers 2024; 16(4): 824 doi: 10.3390/cancers16040824
|
| 12 |
Yunpeng Sun, Qiandong Zhu, Wenjun Yang, Yunfeng Shan, Zhengping Yu, Qiyu Zhang, Huanhuan Wu. LncRNA H19/miR‐194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer. Journal of Cellular Biochemistry 2019; 120(3): 3874 doi: 10.1002/jcb.27669
|
| 13 |
Ganggang Wang, Zenghui Ma, Chao Song, Xiaoliang Wang, Zhijie Zhou. miR-147b is an oncomiR acting synergistically with HIPK2 to promote pancreatic carcinogenesis. Cellular Signalling 2023; 111: 110840 doi: 10.1016/j.cellsig.2023.110840
|
| 14 |
Jeffrey M Sutton, Daniel E Abbott. Neoadjuvant therapy for pancreas cancer: Past lessons and future therapies. World Journal of Gastroenterology 2014; 20(42): 15564-15579 doi: 10.3748/wjg.v20.i42.15564
|
| 15 |
Felipe Fidalgo, Elimar Elias Gomes, Luciana Moredo Facure, Felipe Carneiro Da Silva, Dirce Maria Carraro, Bianca Costa Soares de Sá, João Pedreira Duprat Neto, Ana Cristina Victorino Krepischi. Association of melanoma with intraepithelial neoplasia of the pancreas in three patients. Experimental and Molecular Pathology 2014; 97(1): 144 doi: 10.1016/j.yexmp.2014.06.013
|
| 16 |
Raju Kandimalla, Tadanobu Shimura, Saurav Mallik, Fuminori Sonohara, Susan Tsai, Douglas B. Evans, Song Cheol Kim, Hideo Baba, Yasuhiro Kodera, Daniel Von Hoff, Xi Chen, Ajay Goel. Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma. Annals of Surgery 2022; 275(1): e229 doi: 10.1097/SLA.0000000000003945
|
| 17 |
Jan Bures, Darina Kohoutova, Jan Skrha, Bohus Bunganic, Ondrej Ngo, Stepan Suchanek, Pavel Skrha, Miroslav Zavoral. Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus. Cancers 2023; 15(14): 3669 doi: 10.3390/cancers15143669
|
| 18 |
L. Li, S.L. Zhao, G.G.L. Yue, T.P. Wong, J.X. Pu, H.D. Sun, K.P. Fung, P.C. Leung, Q.B. Han, C.B.S. Lau, P.S. Leung. Isodon eriocalyx and its bioactive component Eriocalyxin B enhance cytotoxic and apoptotic effects of gemcitabine in pancreatic cancer. Phytomedicine 2018; 44: 56 doi: 10.1016/j.phymed.2018.03.055
|
| 19 |
Laura N. Anderson, Michelle Cotterchio, Julia A. Knight, Ayelet Borgida, Steven Gallinger, Sean P. Cleary, Xiao-Ping Miao. Genetic Variants in Vitamin D Pathway Genes and Risk of Pancreas Cancer; Results from a Population-Based Case-Control Study in Ontario, Canada. PLoS ONE 2013; 8(6): e66768 doi: 10.1371/journal.pone.0066768
|
| 20 |
Molecular Processes Involved in Pancreatic Cancer and Therapeutics. Current Chemical Biology 2021; 15(1): 85 doi: 10.2174/2212796814999201008130819
|
| 21 |
Mohini Singh, Paulami Pal, Rajat Subhra Dutta, Daphisha Marbaniang, Subhabrata Ray, Bhaskar Mazumder. Nanodiamond Mediated Molecular Targeting in Pancreatic Ductal Adenocarcinoma:
Disrupting the Tumor-stromal Cross-talk, Next Hope on the
Horizon?. Current Cancer Drug Targets 2023; 23(8): 620 doi: 10.2174/1568009623666230227120837
|
| 22 |
Paola Ghiorzo. Genetic predisposition to pancreatic cancer. World Journal of Gastroenterology 2014; 20(31): 10778-10789 doi: 10.3748/wjg.v20.i31.10778
|
| 23 |
Volker Fendrich. Chemoprevention of pancreatic cancer—one step closer. Langenbeck's Archives of Surgery 2012; 397(4): 495 doi: 10.1007/s00423-012-0916-x
|
| 24 |
Silviu Stanciu, Florentina Ionita-Radu, Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga. Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects. International Journal of Molecular Sciences 2022; 23(17): 10132 doi: 10.3390/ijms231710132
|
| 25 |
XI ZHENG, XIAO-XING CUI, ZHI GAO, MICHAEL VERANO, MOU-TUAN HUANG, YUE LIU, ARNOLD B. RABSON, ALLAN H. CONNEY. Effects of 12-O-tetradecanoylphorbol-13-acetate in combination with gemcitabine on Panc-1 pancreatic cancer cells cultured in vitro or Panc-1 tumors grown in immunodeficient mice. International Journal of Oncology 2012; 41(6): 2269 doi: 10.3892/ijo.2012.1651
|
| 26 |
Alexander Muckenhuber, Anne Katrin Berger, Anna Melissa Schlitter, Katja Steiger, Björn Konukiewitz, Andreas Trumpp, Roland Eils, Jens Werner, Helmut Friess, Irene Esposito, Günter Klöppel, Güralp O. Ceyhan, Moritz Jesinghaus, Carsten Denkert, Marcus Bahra, Albrecht Stenzinger, Martin R. Sprick, Dirk Jäger, Christoph Springfeld, Wilko Weichert. Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response. Clinical Cancer Research 2018; 24(2): 351 doi: 10.1158/1078-0432.CCR-17-2180
|
| 27 |
Demet Kaçaroğlu, Seher Yaylacı, Nilgun Gurbuz. Anti‐tumorigenic effects of naive and TLR4‐primed adipose‐derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells. Cancer Medicine 2024; 13(2) doi: 10.1002/cam4.6964
|
| 28 |
Alexander Muckenhuber, Galina Babitzki, Marlene Thomas, Gabriele Hölzlwimmer, Magdalena Zajac, Moritz Jesinghaus, Frank Bergmann, Jens Werner, Albrecht Stenzinger, Wilko Weichert. Profiling of cMET and HER Family Receptor Expression in Pancreatic Ductal Adenocarcinomas and Corresponding Lymph Node Metastasis to Assess Relevant Pathways for Targeted Therapies. Pancreas 2016; 45(8): 1167 doi: 10.1097/MPA.0000000000000604
|
| 29 |
Jiankun Gao, Fazlul H. Sarkar, Lucio Miele, Zhiwei Wang. Molecular Diagnostics and Treatment of Pancreatic Cancer. 2014; : 75 doi: 10.1016/B978-0-12-408103-1.00004-2
|
| 30 |
Sreedhar Venkannagari, Warren Fiskus, Karissa Peth, Peter Atadja, Manuel Hidalgo, Anirban Maitra, Kapil N. Bhalla. Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer. Oncotarget 2012; 3(11): 1416 doi: 10.18632/oncotarget.724
|
| 31 |
Linda S. Lee, Andrew M. Bellizzi, Peter A. Banks, Nisha I. Sainani, Vivek Kadiyala, Shadeah Suleiman, Darwin L. Conwell, Joao A. Paulo. Differentiating Branch Duct and Mixed IPMN in Endoscopically Collected Pancreatic Cyst Fluid via Cytokine Analysis. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/247309
|
| 32 |
Sheeja Aravindan, Caroline R. Delma, Somasundaram S. Thirugnanasambandan, Terence S. Herman, Natarajan Aravindan, Aamir Ahmad. Anti-Pancreatic Cancer Deliverables from Sea: First-Hand Evidence on the Efficacy, Molecular Targets and Mode of Action for Multifarious Polyphenols from Five Different Brown-Algae. PLoS ONE 2013; 8(4): e61977 doi: 10.1371/journal.pone.0061977
|
| 33 |
Francesco Sclafani, Ridhima Iyer, David Cunningham, Naureen Starling. Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets. Critical Reviews in Oncology/Hematology 2015; 95(3): 318 doi: 10.1016/j.critrevonc.2015.03.008
|
| 34 |
Peter K. Vogt. Retroviral oncogenes: a historical primer. Nature Reviews Cancer 2012; 12(9): 639 doi: 10.1038/nrc3320
|
| 35 |
Ashley L. Hein, Parthasarathy Seshacharyulu, Satyanarayana Rachagani, Yuri M. Sheinin, Michel M. Ouellette, Moorthy P. Ponnusamy, Marc C. Mumby, Surinder K. Batra, Ying Yan. PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling. Cancer Research 2016; 76(8): 2243 doi: 10.1158/0008-5472.CAN-15-2119
|
| 36 |
Farah Rahman, Michelle Cotterchio, Sean P. Cleary, Steven Gallinger, Osama Ali Abulseoud. Association between Alcohol Consumption and Pancreatic Cancer Risk: A Case-Control Study. PLOS ONE 2015; 10(4): e0124489 doi: 10.1371/journal.pone.0124489
|
| 37 |
Nikolaos Symeonidis, Maria Lambropoulou, Efstathios Pavlidis, Constantinos Anagnostopoulos, Alexandra Tsaroucha, Athanasia Kotini, Christina Nikolaidou, Anastasia Kiziridou, Constantinos Simopoulos. PAK1 Expression in Pancreatic Cancer: Clinicopathological Characteristics and Prognostic Significance. Clinical Medicine Insights: Oncology 2019; 13: 117955491983199 doi: 10.1177/1179554919831990
|
| 38 |
Savio George Barreto. Surgical Diseases of the Pancreas and Biliary Tree. 2018; : 427 doi: 10.1007/978-981-10-8755-4_16
|
| 39 |
Maryum Nisar, Rehan Zafar Paracha, Alvina Gul, Iqra Arshad, Saima Ejaz, Didar Murad, Shahzeb Khan, Zartasha Mustansar. Interaction Analysis of Adenovirus L5 Protein With Pancreatic Cancer Cell Surface Receptor to Analyze Its Affinity for Oncolytic Virus Therapy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.832277
|
| 40 |
Dannel Yeo, Hong He, Oneel Patel, Andrew M. Lowy, Graham S. Baldwin, Mehrdad Nikfarjam. FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2057-z
|
| 41 |
Ana De Jesus-Acosta, Amol Narang, Lauren Mauro, Joseph Herman, Elizabeth M. Jaffee, Daniel A. Laheru. Abeloff's Clinical Oncology. 2020; : 1342 doi: 10.1016/B978-0-323-47674-4.00078-5
|
| 42 |
Saad Sabbar Dahham, Yasser M. Tabana, Loiy E. Ahmed Hassan, Mohamed B. Khadeer Ahamed, Aman Shah Abdul Majid, Amin Malik Shah Abdul Majid. In vitro antimetastatic activity of Agarwood (Aquilaria crassna) essential oils against pancreatic cancer cells. Alexandria Journal of Medicine 2016; 52(2): 141 doi: 10.1016/j.ajme.2015.07.001
|
| 43 |
Cecilia Roux, Chiara Riganti, Sammy Ferri Borgogno, Roberta Curto, Claudia Curcio, Valeria Catanzaro, Giuseppe Digilio, Sergio Padovan, Maria Paola Puccinelli, Monica Isabello, Silvio Aime, Paola Cappello, Francesco Novelli. Endogenous glutamine decrease is associated with pancreatic cancer progression. Oncotarget 2017; 8(56): 95361 doi: 10.18632/oncotarget.20545
|
| 44 |
Yehuda Handelsman, Derek LeRoith, Zachary T. Bloomgarden, Samuel Dagogo-Jack, Daniel Einhorn, Alan J. Garber, George Grunberger, R. Mack Harrell, Robert F. Gagel, Harold E. Lebovitz, Janet B. McGill, Charles H. Hennekens. Diabetes and Cancer—An AACE/ACE Consensus Statement. Endocrine Practice 2013; 19(4): 675 doi: 10.4158/EP13248.CS
|
| 45 |
Yasushi SHIBASAKI, Takanori SAKAGUCHI, Keisuke INABA, Shohachi SUZUKI, Satoshi BABA, Hiroyuki KONNO. Intraductal tubulopapillary neoplasm of the pancreas successfully treated with total pancreatectomy. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2012; 73(8): 2061 doi: 10.3919/jjsa.73.2061
|
| 46 |
Angela Proctor, S. Gabriela Herrera-Loeza, Qunzhao Wang, David S. Lawrence, Jen Jen Yeh, Nancy L. Allbritton. Measurement of Protein Kinase B Activity in Single Primary Human Pancreatic Cancer Cells. Analytical Chemistry 2014; 86(9): 4573 doi: 10.1021/ac500616q
|
| 47 |
William Bruno, Giuseppe Fornarini, Paola Ghiorzo. Signs and genetics of rare cancer syndromes with gastroenterological features. World Journal of Gastroenterology 2015; 21(30): 8985-8993 doi: 10.3748/wjg.v21.i30.8985
|
| 48 |
V. Heinemann, M. Reni, M. Ychou, D.J. Richel, T. Macarulla, M. Ducreux. Tumour–stroma interactions in pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategies. Cancer Treatment Reviews 2014; 40(1): 118 doi: 10.1016/j.ctrv.2013.04.004
|
| 49 |
Michela Visani, Dario de Biase, Paola Baccarini, Carlo Fabbri, Anna Maria Polifemo, Nicola Zanini, Annalisa Pession, Giovanni Tallini. MultipleKRASMutations in Pancreatic Adenocarcinoma. International Journal of Surgical Pathology 2013; 21(6): 546 doi: 10.1177/1066896912475073
|
| 50 |
Joseph M. Herman, Christopher H. Crane, Christine Iacobuzio-Donahue, Ross A. Abrams. Clinical Radiation Oncology. 2016; : 934 doi: 10.1016/B978-0-323-24098-7.00048-4
|
| 51 |
Samuel O. Antwi, William R. Bamlet, Richard M. Cawthon, Kari G. Rabe, Brooke R. Druliner, Hugues Sicotte, Aminah Jatoi, Amit Mahipal, Lisa A. Boardman, Ann L. Oberg, Gloria M. Petersen. Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma. Cancer Epidemiology, Biomarkers & Prevention 2021; 30(1): 210 doi: 10.1158/1055-9965.EPI-20-1279
|
| 52 |
Jun Xia, Changjie Chen, Zhiwen Chen, Lucio Miele, Fazlul H. Sarkar, Zhiwei Wang. Targeting pancreatic cancer stem cells for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012; 1826(2): 385 doi: 10.1016/j.bbcan.2012.06.002
|
| 53 |
Anna J. Boland, Anthony A. O’Kane, Richard Buick, Daniel B. Longley, Christopher J. Scott. Antibody therapy in pancreatic cancer: mAb-ye we’re onto something?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(1): 188557 doi: 10.1016/j.bbcan.2021.188557
|
| 54 |
Michael R. Ludwig, Kyoko Kojima, Gregory J. Bowersock, Dongquan Chen, Nirag C. Jhala, Donald J. Buchsbaum, William E. Grizzle, Christopher A. Klug, James A. Mobley. Surveying the serologic proteome in a tissue‐specific kras(G12D) knockin mouse model of pancreatic cancer. PROTEOMICS 2016; 16(3): 516 doi: 10.1002/pmic.201500133
|
| 55 |
Si Shi, Shunrong Ji, Yi Qin, Jin Xu, Bo Zhang, Wenyan Xu, Jiang Liu, Jiang Long, Chen Liu, Liang Liu, Quanxing Ni, Xianjun Yu. Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer. Cancer Letters 2015; 360(2): 227 doi: 10.1016/j.canlet.2015.02.014
|
| 56 |
BIN LIU, ZHEN WANG, HONG-YU LI, BO ZHANG, BO PING, YING-YI LI. Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis. Oncology Reports 2014; 31(6): 2625 doi: 10.3892/or.2014.3158
|
| 57 |
Malaina Gaddis, Diana Gerrard, Seth Frietze, Peggy J Farnham. Altering cancer transcriptomes using epigenomic inhibitors. Epigenetics & Chromatin 2015; 8(1) doi: 10.1186/1756-8935-8-9
|
| 58 |
Tereza Halkova, Romana Cuperkova, Marek Minarik, Lucie Benesova. MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and Prognosis. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/892903
|